Ferrosan's main shareholder puts shares up for sale  

2004.11.26
The main shareholder of the Danish consumer healthcare company Ferrosan, Sonnich Fryland, has put his shares up for sale

The main shareholder of consumer healthcare company Ferrosan, Sonnich Fryland, has put his shares up for sale. Based on operational profits and adjusted for company debts, the value of the shares is estimated to be between DKK 350 mn (USD 63 mn) to 500 mn (USD 90 mn) according to financial newspaper Børsen which reports the news. The company's cash flow and operating profits of DKK 108 mn in 2003 is thought to be sufficiently solid for private equity funds to take an interest in acquiring the shares.

 

Since delivering a disappointing result in 2002, Ferrosan has shown strongly increasing revenues and profits, and the company now has enough strength to make an entry into the US market with skin nutrition tablet Imedeen as the spearhead product.

 

Ferrosan operates in two business segments: supplements & lifestyle products, and medical devices. More than 90% of its annual sales of about DKK 760 mn (USD 137 mn) are generated outside Denmark. The company is headquartered in Copenhagen and employs around 570 people.

 

Link > Ferrosan 

Next step

Explore business cases

Please contact me

Name
Company
E-mail
Phone
How can we help you?

IDK
We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×